Sight Sciences, Inc.
SGHT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001531177
In the last 90 days, Sight Sciences, Inc. insiders filed 0 open-market purchases and 5 sales; 112 institutions reported holding it in 13F filings for Q2 2026, worth $118.5M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 5, 2026, 12:17 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $38.4M (49.7% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 13, 2026 | Jan 14, 2025 | Mar 7, 2024 | Jan 9, 2023 | Jan 10, 2022 |
| Revenue | $77.4M | $79.9M | $81.1M | $71.3M | $49.0M |
| Cost of revenue | $10.7M | $11.6M | $11.9M | $12.4M | $8.61M |
| Gross profit | $66.7M | $68.3M | $69.2M | $59.0M | $40.3M |
| Operating expenses | $103.8M | $118.8M | $126.4M | $142.9M | $91.8M |
| Research and development | $14.6M | $18.0M | $17.6M | $22.9M | $15.6M |
| Selling, general and administrative | $89.2M | $100.8M | $108.9M | $120.1M | $76.2M |
| Operating income | -$37.1M | -$50.5M | -$57.3M | -$84.0M | -$51.5M |
| Interest expense | $5.14M | $4.66M | $5.41M | $4.47M | $4.37M |
| Income tax | $10.0K | $236.0K | $110.0K | $47.0K | $188.0K |
| Net income | -$38.4M | -$51.5M | -$55.5M | -$86.2M | -$63.0M |
| EPS, basic | $-0.74 | $-1.03 | $-1.14 | $-1.80 | – |
| EPS, diluted | $-0.74 | $-1.03 | $-1.14 | $-1.80 | – |
| Weighted shares, basic | 52.1M | 50.1M | 48.6M | 47.8M | – |
| Weighted shares, diluted | 52.1M | 50.1M | 48.6M | 47.8M | – |
| Margins and growth | |||||
| Gross margin | 86.2% | 85.5% | 85.3% | 82.7% | 82.4% |
| Operating margin | -48.0% | -63.3% | -70.7% | -117.7% | -105.2% |
| Net margin | -49.7% | -64.5% | -68.5% | -120.9% | -128.6% |
| Revenue growth, year over year | −3.1% | −1.5% | +13.6% | +45.7% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 13, 2026 | Jan 14, 2025 | Mar 7, 2024 | Jan 9, 2023 | Jan 10, 2022 |
| Cash and equivalents | $92.0M | $120.4M | $138.1M | $185.0M | $260.7M |
| Accounts receivable | $9.74M | $10.8M | $14.3M | $15.1M | $8.71M |
| Inventory | $7.77M | $6.33M | $7.85M | $6.11M | $3.48M |
| Total current assets | $112.7M | $139.8M | $162.9M | $209.7M | $277.0M |
| Property, plant and equipment | $1.61M | $1.58M | $1.64M | $1.57M | $1.45M |
| Total assets | $115.3M | $142.8M | $166.7M | $213.1M | $280.2M |
| Accounts payable | $1.34M | $1.69M | $1.73M | $2.69M | $3.35M |
| Short-term debt | $0 | $0 | $2.22M | $0 | $0 |
| Total current liabilities | $11.0M | $15.5M | $12.3M | $17.8M | $13.5M |
| Long-term debt | $40.3M | $39.4M | $31.7M | $33.3M | $32.7M |
| Total liabilities | $51.4M | $55.3M | $46.4M | $53.0M | $48.1M |
| Shareholders' equity | $63.9M | $87.5M | $120.2M | $160.1M | $232.1M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 13, 2026 | Jan 14, 2025 | Mar 7, 2024 | Jan 9, 2023 | Jan 10, 2022 |
| Operating cash flow | -$29.7M | -$22.4M | -$47.2M | -$76.0M | -$52.5M |
| Capital expenditures | $224.0K | $385.0K | $791.0K | $970.0K | $813.0K |
| Free cash flow | -$29.9M | -$22.7M | -$48.0M | -$76.9M | -$53.4M |
| Depreciation and amortization | $487.0K | $712.0K | – | – | – |
| Stock-based compensation | $13.1M | $17.1M | $14.6M | $13.0M | $5.08M |
| Investing cash flow | -$224.0K | -$385.0K | -$791.0K | -$970.0K | -$813.0K |
| Financing cash flow | $1.79M | $4.96M | $1.10M | $1.25M | $252.5M |
| Net change in cash | -$28.1M | -$17.8M | -$46.9M | -$75.7M | $199.2M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 16.9% | 21.4% | 18.0% | 18.2% | 10.4% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 29, 2026 | 55.6M | +5.1% | SEC |
| Jul 31, 2026 | 55.1M | +5.2% | SEC |
| Apr 30, 2026 | 54.4M | +5.2% | SEC |
| Feb 26, 2026 | 54.0M | +5.2% | SEC |
| Oct 31, 2025 | 52.9M | +4.2% | SEC |
| Aug 1, 2025 | 52.4M | +4.1% | SEC |
| May 2, 2025 | 51.7M | +3.9% | SEC |
| Feb 27, 2025 | 51.3M | +3.6% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.